Fresenius Medical Care AG (XSWX:FME) Price-to-Tangible-Book: (As of Sep. 09, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XSWX:FME Fresenius Medical Care AG XSWX:FME
76 GF Score
Price CHF37.31
GF Value CHF40.60
! 3 Warning Signs
View Full Analysis

What is Fresenius Medical Care AG Price-to-Tangible-Book?

As of today (2026-09-09), Fresenius Medical Care AG's share price is CHF37.31. Fresenius Medical Care AG's Tangible Book per Share of Jun. 2026 for the quarter that ended in Jun. 2026 was CHF-9.31. Hence, Fresenius Medical Care AG's Price to Tangible Book Ratio of today is .

The historical rank and industry rank for Fresenius Medical Care AG's Price-to-Tangible-Book or its related term are showing as below:

XSWX:FME's Price-to-Tangible-Book is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 2.57
* Ranked among companies with meaningful Price-to-Tangible-Book only.

A closely related ratio is called PB Ratio. As of today, Fresenius Medical Care AG's share price is CHF37.31. Fresenius Medical Care AG's Book Value per Sharefor the quarter that ended in Jun. 2026 was CHF43.45. Hence, Fresenius Medical Care AG's P/B Ratio of today is 0.86.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.


Fresenius Medical Care AG Price-to-Tangible-Book Related Terms


Fresenius Medical Care AG Price-to-Tangible-Book Historical Data

* Premium members only.

The historical data trend for Fresenius Medical Care AG's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Fresenius Medical Care AG Price-to-Tangible-Book Chart

Fresenius Medical Care AG Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Price-to-Tangible-Book
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Fresenius Medical Care AG Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Price-to-Tangible-Book Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

XSWX:FME vs HCA, THC, EHC: Price-to-Tangible-Book Comparison

For the Medical Care Facilities subindustry, Fresenius Medical Care AG's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Fresenius Medical Care AG Price-to-Tangible-Book vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Fresenius Medical Care AG's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Fresenius Medical Care AG's Price-to-Tangible-Book falls into.


XSWX:FME
76GF Score
Fresenius Medical Care AG XSWX:FME
Price-to-Tangible-Book is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Fresenius Medical Care AG Price-to-Tangible-Book Calculation

Fresenius Medical Care AG's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book=Share Price/Tangible Book per Share (Q: Jun. 2026 )
=37.31/-9.313
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.

Is Fresenius Medical Care AG (XSWX:FME) Overvalued in 2026?

Based on GuruFocus' analysis, Fresenius Medical Care AG stock appears to be undervalued. The current stock price of CHF37.31 is trading 8.1% below its estimated GF Value™ of CHF40.60.

Key valuation signals for XSWX:FME:

  • Price-to-Tangible-Book:
  • GF Value™: CHF40.60 vs. price of CHF37.31 (8.1% below fair value)
  • GF Score™: 76/100 with 3 warning signs

No single metric tells the full story. See the XSWX:FME stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Fresenius Medical Care AG Business Description

Address Else-Kroner-Strasse 1, Bad Homburg, HE, DEU, 61352
Fresenius Medical Care is the largest dialysis company in the world, treating nearly 300,000 patients from about 3,600 clinics worldwide as of December 2025. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market, creating the world's only fully integrated dialysis business. Services account for about three-fourths of sales, while the balance is generated from medical technology products that enable dialysis treatments.
76GF Score

Get the complete analysis for XSWX:FME

Price-to-Tangible-Book is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF37.31
Price
CHF40.60
GF Value